Characterization of the Cyno-EBV LMP1 homologue and comparison with LMP1s of EBV and other EBV-like viruses

Virus Research

Volumn 90, Issue 1-2, 2002, Pages 63-75

  Faucher, Sylvie ^a,b   Dimock, Kenneth ^a   Wright, Kathryn E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

CAT assay; Cynomolgus monkey; Epstein Barr virus; Latent membrane protein 1 gene; Macaca fascicularis; Sequence alignment

Indexed keywords

HISTIDINE; LATENT MEMBRANE PROTEIN 1; POLYPEPTIDE; PROLINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN; CONTROLLED STUDY; EMBRYO; EPSTEIN BARR VIRUS; GENETIC CODE; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; VIRUS CHARACTERIZATION; VIRUS STRAIN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, VIRAL; CLONING, MOLECULAR; HERPESVIRUS 4, HUMAN; HUMANS; MACACA FASCICULARIS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSFECTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MACACA; MACACA FASCICULARIS;

EID: 0036890912     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00144-2     Document Type: Article

References (74)

1. Appel R.D., Bairoch A., Hochstrasser D.F. A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem. Sci. 19:1994;258-260.
2. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., Barrell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
3. Baichwal V.R., Sugden B. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J. Virol. 61:1987;866-875.
4. Baichwal V.R., Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene. 2:1988;461-467.
5. Birkenbach M., Liebowitj D., Wang F., Sample J., Kieff E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J. Virol. 63:1989;4079-4084.
6. Bocker J.F., Tiedemann K.H., Bornkamm G.W., zur Hausen H. Characterization of an EBV-like virus from African green monkey lymphoblasts. Virology. 101:1980;291-295.
7. Brodeur S.R., Cheng G., Baltimore D., Thorley-Lawson D.A. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272:1997;19777-19784.
8. Chen M.L., Tsai C.N., Liang C.L., Shu C.H., Huang C.R., Sulitzeanu D., Liu S.T., Chang Y.S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene. 7:1992;2131-2140.
9. D'Souza B., Rowe M., Walls D. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J. Virol. 74:2000;6652-6658.
10. Devergne O., Hatzivassiliou E., Izumi K.M., Kaye K.M., Kleijnen M.F., Kieff E., Mosialos G. Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell Biol. 16:1996;7098-7108.
11. Devergne O., McFarland E.C., Mosialos G., Izumi K.M., Ware C.F., Kieff E. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72:1998;7900-7908.
12. Dillner J., Rabin H., Letvin N., Henle W., Henle G., Klein G. Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pun, H. pongo and H. papio. J. Gen. Virol. 87:1987;1587-1596.
13. Eliopoulos A.G., Dawson C.W., Mosialos G., Floettmann J.E., Rowe M., Armitage R.J., Dawson J., Zapata J.M., Kerr- D.J., Wakelam M.J., Reed J.C., Kieff E., Young L.S. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene. 13:1996;2243-2254.
14. Eliopoulos A.G., Blake S.M., Floettmann J.E., Rowe M., Young L.S. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73:1999;1023-1035.
15. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., Young L.S. Activation of the p3B mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:1999;16085-16096.
16. Falk L., Deinhardt F., Nonoyama M., Wolfe L.G., Bergholz C. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int. J. Cancer. 18:1976;798-807.
17. Falk L.A., Henle G., Henle W., Deinhardt F., Schudel A. Transformation of lymphocytes by Herpesvirus papio. Int. J. Cancer. 20:1977;219-226.
18. Feichtinger H., Putkonen P., Parravicini C., Li S.L., Kaaya E.E., Bottiger D., Biberfeld G., Biberfeld P. Malignant lymphomas in Cynomolgus monkeys infected with simian immunodeficiency virus. Am. J. Pathol. 137:1990;1311-1315.
19. Feichtinger H., Li S.L., Kaaya E., Putkonen P., Grunewald K., Weyrer K., Bottiger D., Ernberg I., Linde A., Biberfeld G., Biberfeld P. A monkey model for Epstein-Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J. Exp. Med. 176:1992;281-286.
20. Floettmann J.E., Rowe M. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation. Oncogene. 15:1997;1851-1858.
21. Franken M., Devergne O., Rosenzweig M., Annis B., Kieff E., Wang F. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:1996;7819-7826.
22. Fries K.L., Sculley T.B., Webster-Cyriaque J., Rajadurai P., Sailler R.H., Raab-Traub N. Identification of a novel protein encoded by the BamH1 A region of the Epstein-Barr virus. J. Virol. 71:1997;2765-2771.
23. Fujimoto K., Terato K., Miyamoto J., Ishiko H., Fujisaki M., Cho F., Honjo S. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr related virus from a Cynomolgus monkey (Macaca fascicularis). J. Med. Primat. 19:1990;21-30.
24. Gerber P., Kalter S.S., Schidlovsky G., Peterson W.D.J., Daniel M.D. Biologic and antigenic characteristics of Epstein-Barr virus-related herpesvirus of chimpanzees and baboons. Int. J. Cancer. 20:1977;448-459.
25. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16:1997;6131-6140.
26. Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:1999;3064-3073.
27. Hammerschmidt W., Sugden B., Baichwal V.R. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:1989;2469-2475.
28. Hatfull G., Bankier A.T., Barrell B.G., Farrell P.J. Sequence analysis of Raji Epstein-Barr virus DNA. Virology. 164:1988;334-340.
29. Hayashi K., Ohara N., Koirala T.R., Ino H., Chen H.L., Teramoto N., Kondo E., Yoshino T., Takahashi K., Yamada M. HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA). Jpn. J. Cancer Res. 85:1994;808-818.
30. Hayashi K., Koirala T.R., Ino H., Chen H.L., Ohara N., Teramoto N., Yoshino T., Takahashi K., Yamada M., Nii S. Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr-virus-related herpesvirus from HTLV-II-transformed Cynomolgus leukocyte cell line (Si-IIA). Int. J. Cancer. 63:1995;872-880.
31. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bel-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
32. Higuchi M., Izumi K.M., Kieff E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA. 98:2001;4675-4680.
33. Huen D.S., Henderson S.A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protem-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
34. Ishida T., Yamamoto K. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV. J. Med. Primat. 16:1987;359-371.
35. Izumi K.M., McFarland E.G., Ting A.T., Riley E.A., Seed B., Kieff E.D. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Mol. Cell Biol. 19:1999;5759-5767.
36. Kalter S.S., Heberling R.L., Ratner J.J. EBV antibody in sera of non-human primates. Nature. 238:1972;353-354.
37. Kawanishi M. The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. Virology. 270:2000;258-266.
38. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NP-kappa B activation by latent infection membrane protein 1 the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA. 93:1996;11085-11090.
39. Kieff E. Epstein-Barr virus and its replication. Fields B.N., Knipe D.M., Howley P.M. Fundamental Virology. 1996;1109-1146 Lippincott-Raven, Philadelphia.
40. 2+. Biochem. Biophys. Res. Commun. 216:1995;209-215.
41. Laherty C.D., Hu H.M., Opipari A.W., Wang F., Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267:1992;24157-24160.
42. Li S.L., Feichtinger H., Kaaya E., Migliorini P., Putkonen P., Biberfeld G., Middeldorp J.M., Biberfeld P., Ernberg I. Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys. Int. J. Cancer. 55:1993;609-615.
43. Li S.L., Biberfeld P., Ernberg I. DNA of lymphoma-associated herpesvirus (HVMF1) in SIV-infected monkeys (Macaca fascicularis) shows homologies to EBNA-1, -2 and-5 genes. Int. J. Cancer. 59:1994;287-295.
44. Ling P.D., Ryon J.J., Hayward S.D. EBNA-2 of Herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:1993;2990-3003.
45. Lu J.J., Chen J.Y., Hsu T.Y., Yu W.C., Su I.J., Yang C.S. Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 77:(Pt 8):1996;1883-1892.
46. Luckow B., Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucl. Acids Res. 15:1987;5490.
47. Martin J.M., Veis D., Korsmeyer S.J., Sugden B. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bel-2. J. Virol. 67:1993;5269-5278.
48. McClure H.M. Tumors in nonhuman primates: observations during a six-year period in the Yerkes primate center colony. Am. J. Phys. Anthropol. 38:1973;425-429.
49. Mehl A.M., Fischer N., Rowe M., Hartmann F., Daus H., Trumper L., Pfreundschuh M., Muller-Lantzsch N., Grasser F.A. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus (EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma. Int. J. Cancer. 76:1998;194-200.
50. Miller W.E., Earp H.S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:1995;4390-4398.
51. Mitchell T., Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:1995;2968-2976.
52. Miyamoto K., Tomita N., Hayashi K., Akagi T. Transformation of animal cells with human T-cell leukemia virus type II. Jpn. J. Cancer Res. 81:1990;720-722.
53. Moorthy R.K., Thorley-Lawson D.A. Biochemical, genetic and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J. Virol. 67:1993;2637-2645.
54. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
55. Neubauer R.H., Rabin H., Strnad B.C., Nonoyama M., Nelson-Rees W.A. Establishment of a lymphoblastoid cell line and isolation of an Epstein-Barr-related virus of gorilla origin. J. Virol. 79:1979;845-848.
56. Ohno S., Luka J., Falk L., Klein G. Detection of a nuclear, EBNA-type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique. Int. J. Cancer. 77:1977;941-946.
57. Peng M., Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21 and 1CAM-1. Leukemia. 7:1993;104-112.
58. Pennock J.L., Reitz B.A., Bieber C.P., Aziz S., Oyer P.E., Strober S., Hoppe R., Kaplan H.S., Stinson E.B., Shumway N.E. Survival of primates following orthotopic cardiac transplantation treated with total lymphoid irradiation and chemical immune supression. Transplantation. 32:1981;467-473.
59. Rabin H., Neubauer R.H., Hopkins R.F. III, Dzhikidze E.K., Shevtsova Z.V., Lapin B.A. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Intervirology. 77:(8):1977;240-249.
60. Rabin H., Strnad B.C., Neubauer R.H., Brown A.M., Hopkins R.F. III, Mazur R.A. Comparisons of nuclear antigens of Epstein-Barr virus (EBV) and EBV-like simian viruses. J. Gen. Virol. 80:1980;265-272.
61. Rangan S.R., Martin L.N., Bozelka B.E., Wang N., Gormus B.J. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int. J. Cancer. 38:1986;425-432.
62. Rasheed S., Rongey R.W., Bruszweski J., Nelson-Rees W.A., Rabin H., Neubauer R.H., Esra G., Gardner M.B. Establishment of a cell line with associated Epstein-Barr-like virus from a leukemic orangutan. Science. 77:1977;407-409.
63. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta. 1451:1999;1-16.
64. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
65. Sandberg M., Hammerschmidt W., Sugden B. Characterization of LMP-1s association with TRAF1, TRAF2 and TRAF3. J. Virol. 71:1997;4649-4656.
66. Smith C., Lilly S., Mann K.P., Livingston E., Myers S., Lyerly H.K., Miralles G.D. AIDS-related malignancies. Ann. Med. 30:1998;323-344.
67. Sonnhammer E.L.L., von Heijne G., Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Glasgow J., Littlejohn T., Major F., Lathrop R., Sankoff D., Sensen C. Proceedings of Sixth International Conference on Intelligent Systems for Molecular Biology. 1998;175-182 AAAI Press, Menlo Park, CA.
68. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
69. Thorley-Lawson D.A., Miyashita E.M., Khan G. Epstein-Barr virus and the B cell: thats all it takes. Trends Microbiol. 4:1996;204-208.
70. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
71. Vogelstein B., Gillespie D. Preparative and analytical purification of DNA from agarose. Proc. Natl. Acad. Sci. USA. 76:1979;615-619.
72. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:1985;831-840.
73. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62:1988;4173-4184.
74. Wang S., Rowe M., Lundgren E. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 56:1996;4610-4613.